MicroTech Medical (Hangzhou) Co., Ltd. (2235.HK)
Makes insulin pumps and glucose monitors for managing diabetes
7.10+0.00%Healthcare
StockGlow Score
Neutral
BearishBullish
1 year ago+5.8%
The outlook
MicroTech Medical trades at 7.1 with analyst consensus leaning Buy, though coverage is modest at three analysts. The stock sits well below both its 50- and 200-day averages, positioning it in the lower portion of its 52-week range. The average analyst price target sits roughly 67% above the current price, though the trailing P/E of 59.2 reflects elevated valuation relative to near-term earnings.
What’s behind the score
Analyst consensusBuy — 2.0 avg of 3 analysts
Price trendBelow its 50- & 200-day averages
52-week range40% of the way from its 52-week low to high
Price targetAvg target +67% vs current price
Analyst price target
~12-month · 3 analysts11.82average target+66.5% vs now
Now 7.10
Low 8.70High 14.65
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$2.91B
52-wk high
9.17
52-wk low
5.70
50-day avg
7.34
200-day avg
7.35
Trailing P/E
59.2